16-50674023-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_182854.4(SNX20):c.334G>A(p.Val112Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,610,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_182854.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SNX20 | NM_182854.4 | c.334G>A | p.Val112Ile | missense_variant | 4/4 | ENST00000330943.9 | |
SNX20 | NM_001144972.2 | c.282+1747G>A | intron_variant | ||||
SNX20 | NM_153337.3 | c.282+1747G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SNX20 | ENST00000330943.9 | c.334G>A | p.Val112Ile | missense_variant | 4/4 | 1 | NM_182854.4 | P1 | |
SNX20 | ENST00000423026.6 | c.282+1747G>A | intron_variant | 1 | |||||
SNX20 | ENST00000568993.5 | c.282+1747G>A | intron_variant, NMD_transcript_variant | 1 | |||||
SNX20 | ENST00000300590.7 | c.282+1747G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245384Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 132952
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1458828Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 725612
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at